Page last updated: 2024-10-28

phenelzine and Parkinson Disease, Secondary

phenelzine has been researched along with Parkinson Disease, Secondary in 4 studies

Phenelzine: One of the MONOAMINE OXIDASE INHIBITORS used to treat DEPRESSION; PHOBIC DISORDERS; and PANIC.

Parkinson Disease, Secondary: Conditions which feature clinical manifestations resembling primary Parkinson disease that are caused by a known or suspected condition. Examples include parkinsonism caused by vascular injury, drugs, trauma, toxin exposure, neoplasms, infections and degenerative or hereditary conditions. Clinical features may include bradykinesia, rigidity, parkinsonian gait, and masked facies. In general, tremor is less prominent in secondary parkinsonism than in the primary form. (From Joynt, Clinical Neurology, 1998, Ch38, pp39-42)

Research

Studies (4)

TimeframeStudies, this research(%)All Research%
pre-19904 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Teusink, JP1
Alexopoulos, GS1
Shamoian, CA1
Gillman, MA1
Sandyk, R1
Patni, SK1
Dandiya, PC2
Bhargava, LP1

Other Studies

4 other studies available for phenelzine and Parkinson Disease, Secondary

ArticleYear
Parkinsonian side effects induced by a monoamine oxidase inhibitor.
    The American journal of psychiatry, 1984, Volume: 141, Issue:1

    Topics: Aged; Depressive Disorder; Female; Humans; Parkinson Disease, Secondary; Phenelzine

1984
Parkinsonism induced by a monoamine oxidase inhibitor.
    Postgraduate medical journal, 1986, Volume: 62, Issue:725

    Topics: Adult; Female; Humans; Parkinson Disease, Secondary; Phenelzine

1986
The influence of monoamine oxidase inhibitors and some other antidepressants on the anti-parkinsonian activity of sub-effective doses of diphenylhydramine in rats and mice.
    Japanese journal of pharmacology, 1972, Volume: 22, Issue:3

    Topics: Animals; Antidepressive Agents; Catatonia; Diphenhydramine; Humans; Mice; Monoamine Oxidase Inhibito

1972
The antiparkinsonian activity of monoamine oxidase inhibitors and other agents in rats and mice.
    Archives internationales de pharmacodynamie et de therapie, 1968, Volume: 176, Issue:1

    Topics: Animals; Dextroamphetamine; Diphenhydramine; Imipramine; Iproniazid; Isocarboxazid; Mice; Monoamine

1968